Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 4:23 PM View:  | Edgewise Therapeutics, Inc. (EWTX) | 11-Oct-24 | Option Exercise | 70,000 | $0.71 | $49,700.00 | 1014% 6.9K to 76.9K | |
| 08-Oct-24 7:21 PM View: | Onkure Therapeutics, Inc. (OKUR) | 04-Oct-24 | Grant | 4,939 | -- | -- | 100% 0 to 4.94K | |
| 24-Sep-24 8:22 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Exercise | 96,068 | $1.93 | $185,411.00 | 267% 35.93K to 132.0K | |
| 24-Sep-24 8:22 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Option Sale | 96,068 | $28.57 | $2,744,740.00 | (73%) 132.0K to 35.93K | |
| 24-Sep-24 8:22 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 20-Sep-24 | Sale | 29,024 | $28.57 | $829,239.00 | (81%) 35.93K to 6.9K | |
| 03-May-24 6:30 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 02-May-24 | Option Sale | 2,157 | $18.91 | $40,788.90 | (6%) 37.39K to 35.23K | |
| 03-May-24 6:30 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 01-May-24 | Option Exercise | 5,208 | -- | -- | 16% 32.18K to 37.39K | |
| 25-Jan-24 4:46 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Option Exercise | 90,000 | $1.93 | $173,700.00 | 310% 29.02K to 119.02K | |
| 25-Jan-24 4:46 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 23-Jan-24 | Option Sale | 90,000 | $15.78 | $1,419,760.00 | (76%) 119.02K to 29.02K | |
| 26-Jun-23 4:28 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 22-Jun-23 | Option Exercise | 10,000 | $0.71 | $7,100.00 | 53% 19.02K to 29.02K | |
| 03-May-23 10:00 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 02-May-23 | Option Sale | 1,336 | $8.90 | $11,896.90 | (8%) 17.46K to 16.13K | |
| 03-May-23 10:00 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 01-May-23 | Option Exercise | 5,208 | -- | -- | 43% 12.25K to 17.46K | |
| 25-May-22 6:11 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 23-May-22 | Option Exercise | 9,000 | $0.71 | $6,390.00 | 300% 3.0K to 12.0K | |
| 05-Dec-16 4:26 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 02-Dec-16 | Market Purchase | 24,000 | $2.09 | $50,256.00 | 100% 0 to 24.0K | 85% |